Published online Feb 19, 2026. doi: 10.5498/wjp.v16.i2.113887
Revised: October 29, 2025
Accepted: December 11, 2025
Published online: February 19, 2026
Processing time: 123 Days and 22.3 Hours
Breast cancer affects over 2.3 million women worldwide annually, with 30%-50% experiencing psychological morbidity, including anxiety and depression. Family functioning plays a crucial role in patients’ psychological adaptation to cancer, yet the specific predictive relationship between family dysfunction dimensions and psychological outcomes remains insufficiently characterized. This study aimed to systematically examine how family dysfunction predicts psychological morbidity in breast cancer patients.
To explore the predictive role of family dysfunction on psychological morbidity in breast cancer patients and develop a clinical risk prediction model.
A retrospective cohort study was conducted among 285 breast cancer patients from June 2022 to March 2025 at a provincial tertiary hospital. Family functioning was assessed using the Family Assessment Device, and psychological health was evaluated using the Hospital Anxiety and Depression Scale. Univariate and multivariate logistic regression analyses were performed to identify predictive factors. A comprehensive risk prediction model was developed and validated.
The overall psychological morbidity rate was 41.5% (n = 118), with anxiety symp
Family dysfunction significantly predicts psychological morbidity in breast cancer patients, with communication dysfunction being the most critical dimension. The developed risk prediction model demonstrates good accuracy for clinical decision-making.
Core Tip: This study demonstrates that family dysfunction, particularly communication problems, is a strong independent predictor of psychological morbidity in breast cancer patients. Using the Family Assessment Device and the Hospital Anxiety and Depression Scale, we developed and validated a clinical risk prediction model with good accuracy. Early identification of family dysfunction allows timely psychological support and family-centered interventions, which may improve mental health outcomes and treatment adherence in breast cancer care.
